Discontinuation report PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2022-07-21 History
Report ID 165193
Drug Identification Number 02401320
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TAZOBACTAM PIPERACILLIN
Strength(s) 0.375G 3G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 3.375G
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-07-21
Actual discontinuation date
Remaining supply date 2022-07-21
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-07-21 French Compare
v1 2022-07-21 English Compare

Showing 1 to 2 of 2